TheProfitWatch

ANRO - Alto Neuroscience Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
5.51 0.63 (11.43%) --- --- --- -0.07 (-1.36%) 0.55 (9.84%) 0.02 (0.33%) 0.02 (0.33%)

Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals' neurobiology to develop personalized and effective treatment options. The company currently consists of different clinical-stage assets such as ALTO-100, ALTO-202, ALTO-101, and ALTO-300 among others initially targeting depressive disorders and schizophrenia populations as identified by independent brain-based biomarkers.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: AfterHours

Earnings & Ratios

Basic EPS:
-0.56
Diluted EPS:
-0.56
Basic P/E:
-10.9643
Diluted P/E:
-10.9643
RSI(14) 1m:
100.0
VWAP:
6.14
RVol:
0.0959

Events

Period Kind Movement Occurred At
1m Price increase 1m 6.18 +0.07 (+1.15%) Oct 15 15:13
1m Price increase 1m 6.13 +0.12 (+2.0%) Oct 15 15:05
Day Price increase day 6.07 +0.56 (+10.16%) Oct 15 14:03
1m Price increase 1m 6.06 +0.07 (+1.13%) Oct 15 13:53
60m Price increase 60m 6.06 +0.35 (+6.08%) Oct 15 13:53

Related News